Details of the Drug

General Information of Drug (ID: DMKDN1C)

• Drug Name: MVA-85A
• Synonyms: AERAS-485; MVA-AG85A; MVA-85A vaccine (Mycobacterium tuberculosis infection), Oxford-Emergent Tuberculosis Consortium/TB-VAC; MVA-Ag85A vaccine (Mycobacterium tuberculosis infection), Oxford-Emergent Tuberculosis Consortium/TB-VAC

Indication

Disease Entry	ICD 11	Status	REF
Mycobacterium infection	1B10-1B21	Phase 2	[1]

• Drug Type: Vaccine
• Cross-matching ID: TTD ID: D07GMF

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Mycobacterium Antigen complex 85A (MycB fbpA)	TTZYJ8U	A85A_MYCTU	Not Available	[2]

References

• [1] ClinicalTrials.gov (NCT01650389) Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination. U.S. National Institutes of Health.
• [2] MVA-85A, a novel candidate booster vaccine for the prevention of tuberculosis in children and adults. Curr Opin Mol Ther. 2010 Feb;12(1):124-34.